SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-008178
Filing Date
2023-03-15
Accepted
2023-03-15 16:34:57
Documents
7
Effectiveness Date
2023-03-15

Document Format Files

Seq Description Document Type Size
1 S-8 ubx-s8-20230315.htm S-8 221914
2 EX-5.1 ubx-ex5_1.htm EX-5 43643
3 EX-23.1 ubx-ex23_1.htm EX-23 3708
4 EX-99.3(C) ubx-ex99_3c.htm EX-99 14762
5 EX-FILING FEES ubx-exfiling_fees.htm EX-FILING FEES 46401
6 GRAPHIC img152857925_0.jpg GRAPHIC 58631
7 GRAPHIC img152857925_1.jpg GRAPHIC 58366
  Complete submission text file 0000950170-23-008178.txt   492975
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270567 | Film No.: 23735746
SIC: 2834 Pharmaceutical Preparations